In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.

作者: Gloria M. González , Annette W. Fothergill , Deanna A. Sutton , Michael G. Rinaldi , David Loebenberg

DOI: 10.1080/13693780500088416

关键词: PaecilomycesPseudallescheria boydiiBlastomyces dermatitidisRavuconazoleSporothrix schenckiiDimorphic fungusCoccidioides immitisFonsecaea pedrosoiMicrobiologyBiology

摘要: The in vitro activities of three new triazoles were determined and compared to those itraconazole fluconazole against 306 clinical isolates Blastomyces dermatitidis, Cladophialophora carrionii, Coccidioides immitis, Fonsecaea pedrosoi, Fusarium spp., Histoplasma capsulatum, Paecilomyces lilacinus, Pseudallescheria boydii Sporothrix schenckii. Minimum inhibitory concentrations (MIC) by a broth macrodilution method the National Committee for Clinical Laboratory Standards M38-A procedure. Itraconazole (geometric mean MIC, 0.16–0.65 μg/ml), voriconazole 0.18–1.44 ravuconazole 0.18–1.09 posaconazole 0.18–1.38 had relatively uniform values showing potent activity B. C. F. H. S. was variable with strains P. boydii, lilacinus spp.

参考文章(21)
T. F. Patterson, V. T. Andriole, M. J. Zervos, D. Therasse, Carol A. Kauffman, The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses. ,vol. 33, pp. 297- 302 ,(1990) , 10.1111/MYC.1990.33.6.296
M G Rinaldi, Use of potato flakes agar in clinical mycology. Journal of Clinical Microbiology. ,vol. 15, pp. 1159- 1160 ,(1982) , 10.1128/JCM.15.6.1159-1160.1982
DOUGLAS G. FISH, NEIL M. AMPEL, JOHN N. GALGIANI, CYNTHIA L. DOLS, PETER C. KELLY, CHARLES H. JOHNSON, DEMOSTHENES PAPPAGIANIS, JOHN E. EDWARDS, RONALD B. WASSERMAN, ROBERT J. CLARK, DIANA ANTONISKIS, ROBERT A. LARSEN, STEVEN J. ENGLENDER, ESKILD A. PETERSEN, Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine. ,vol. 69, pp. 384- 391 ,(1990) , 10.1097/00005792-199011000-00006
Karl V. Clemons, David A. Stevens, Efficacy of Ravuconazole in Treatment of Mucosal Candidosis in SCID Mice Antimicrobial Agents and Chemotherapy. ,vol. 45, pp. 3433- 3436 ,(2001) , 10.1128/AAC.45.12.3433-3436.2001
Harry A. Gallis, Richard H. Drew, William W. Pickard, Amphotericin B: 30 Years of Clinical Experience Clinical Infectious Diseases. ,vol. 12, pp. 308- 329 ,(1990) , 10.1093/CLINIDS/12.2.308
M. R. McGINNIS, L. PASARELL, D. A. SUTTON, A. W. FOTHERGILL, C. R. COOPER Jr, M. G. RINALDI, In vitro activity of voriconazole against selected fungi Medical Mycology. ,vol. 36, pp. 239- 242 ,(1998) , 10.1046/J.1365-280X.1998.00153.X
B. Minassian, E. Huczko, T. Washo, D. Bonner, J. Fung-Tomc, In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates Clinical Microbiology and Infection. ,vol. 9, pp. 1250- 1252 ,(2003) , 10.1111/J.1469-0691.2003.00755.X
Gabriele Ginter, B. Petutschnig, G. Pierer, H. P. Soyer, S. Reischle, T. Kern, S. de Hoog, Case report. Atypical cutaneous pseudallescheriosis refractory to antifungal agents. Mycoses. ,vol. 42, pp. 507- 511 ,(1999) , 10.1046/J.1439-0507.1999.00480.X